Should allopurinol be started or continued during a gout flare-up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Allopurinol Use During Gout Flare-Up

When urate-lowering therapy (ULT) is indicated, allopurinol can be initiated during an acute gout flare rather than waiting for the flare to resolve. 1

Starting Allopurinol During a Gout Flare

  • The 2020 American College of Rheumatology (ACR) guidelines conditionally recommend starting ULT during a gout flare rather than waiting until after the flare has resolved 1
  • The ACR guidelines strongly recommend against delaying ULT initiation until after a flare has resolved 1
  • Clinical trials have demonstrated that initiating allopurinol during an acute gout attack does not prolong the duration or severity of the flare 2, 3

Recommendations for Initiating Allopurinol

Dosing

  • Start with a low dose (100 mg daily) and gradually increase by 100 mg increments at weekly intervals 4
  • Titrate until reaching a serum uric acid level of <6 mg/dL 1, 5
  • Patients with renal impairment require lower starting doses:
    • For creatinine clearance 10-20 mL/min: 200 mg daily
    • For creatinine clearance <10 mL/min: ≤100 mg daily 4

Prophylaxis Requirements

  • When starting allopurinol (during or after a flare), concomitant anti-inflammatory prophylaxis is strongly recommended 1, 5
  • Prophylactic options include:
    • Colchicine (0.6 mg once or twice daily)
    • NSAIDs (e.g., naproxen 250 mg twice daily)
    • Prednisone/prednisolone (if colchicine or NSAIDs are contraindicated) 5, 6
  • Continue prophylaxis for 3-6 months after initiating ULT 1, 7

Evidence Supporting Early Initiation

  • A randomized clinical trial showed no significant difference in pain scores or flare recurrence when allopurinol was started during an acute gout attack compared to delayed initiation 3
  • Another study found no statistically significant difference in days to resolution of acute gout when allopurinol was initiated during the attack (15.4 days vs 13.4 days with placebo, p=0.5) 2
  • Both allopurinol and febuxostat have similar flare risk profiles when initiated with appropriate anti-inflammatory prophylaxis 8

Practical Considerations

  • Proper prophylaxis significantly reduces the frequency and severity of flares during ULT initiation 7
  • Patient education is crucial to explain that any flares during ULT initiation do not indicate treatment failure but rather mobilization of urate crystals 6
  • Factors associated with higher flare risk during ULT initiation include younger age, higher baseline serum urate levels, and absence of tophi 8

Common Pitfalls to Avoid

  • Waiting for complete resolution of a gout flare before starting allopurinol is no longer recommended and may lead to delayed appropriate therapy 1, 5
  • Starting with too high a dose of allopurinol increases flare risk - always begin with 100 mg daily (or lower in renal impairment) 4
  • Failing to provide adequate anti-inflammatory prophylaxis when initiating ULT 5, 7
  • Discontinuing ULT if a flare occurs during treatment initiation 5

By initiating allopurinol during a gout flare with appropriate prophylaxis, you can begin addressing the underlying hyperuricemia sooner without prolonging the acute attack, ultimately improving long-term outcomes for gout patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Does starting allopurinol prolong acute treated gout? A randomized clinical trial.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2015

Guideline

Allopurinol Initiation in Gout Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.